SCHEMBL4139836

SCHEMBL4139836

CCOC(=O)c1cnc(CS)nc1Cl

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.54
KDM4E B2RXH2 2/20 0.54
MAPT P10636 5/20 0.46
HPGD P15428 2/20 0.46
RAB9A P51151 5/20 0.46
NPC1 O15118 5/20 0.46
SMN1; SMN2 Q16637 5/20 0.46
NFKB1 P19838 2/20 0.46
NFKB2 Q00653 2/20 0.46
RELA Q04206 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
TP53 P04637 1/20 0.45
HSP90AA1 P07900 1/20 0.45
TDP1 Q9NUW8 2/20 0.45
HSD17B10 Q99714 2/20 0.44
POLB P06746 1/20 0.44
TSHR P16473 2/20 0.43
MAPK1 P28482 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7726224 0.88 ALDH1A1 (0.56) ALDH1A1KDM4EMAPTHPGDRAB9A
SCHEMBL9589692 0.85 HSP90AA1 (0.55) ALDH1A1KDM4EMAPTHPGDRAB9A
SCHEMBL13447383 0.85 ALDH1A1 (0.54) ALDH1A1KDM4EMAPTHPGDRAB9A
SCHEMBL16682717 0.84 ALDH1A1 (0.53) ALDH1A1KDM4EMAPTHPGDRAB9A
SCHEMBL9589351 0.83 ALDH1A1 (0.52) ALDH1A1KDM4EMAPTHPGDRAB9A
SCHEMBL5805980 0.82 ALDH1A1 (0.56) ALDH1A1KDM4EMAPTHPGDRAB9A
SCHEMBL11098691 0.82 ALDH1A1 (0.56) ALDH1A1KDM4EMAPTHPGDRAB9A
SCHEMBL9588606 0.82 ALDH1A1 (0.51) ALDH1A1KDM4EMAPTHPGDRAB9A
SCHEMBL476310 0.81 ALDH1A1 (0.59) ALDH1A1KDM4EMAPTHPGDRAB9A
SCHEMBL427402 0.81 ALDH1A1 (0.63) ALDH1A1KDM4EMAPTHPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2886540-B1 BICYCLIC SUBSTITUTED PYRIMIDINE COMPOUNDS XUANZHU PHARMA CO LTD (CN) 2017-07-26 EP disclosed
US-9359371-B2 Bicyclic substituted pyrimidine compounds Xuanzhu Pharma Co., Ltd. (CN) 2016-06-07 US disclosed
US-20150232474-A1 Bicyclic Substituted Pyrimidine Compounds Xuanzhu Biopharmaceutical Co., Ltd. (CN) 2015-08-20 US disclosed
EP-2886540-A1 BICYCLIC SUBSTITUTED PYRIMIDINE COMPOUNDS Xuanzhu Pharma Co., Ltd. (CN) 2015-06-24 EP disclosed
US-20090227587-A1 Pyrimidines as inhibitors of phosphoinositide-3-kinases (PI3K) WARNER-LAMBERT COMPANY LLC 2009-09-10 US disclosed
US-7319102-B1 Pyrrolo[2,3-d]pyrimidine cytokine inhibitors THE PROCTER & GAMBLE COMPANY (US) 2008-01-15 US disclosed
EP-1682532-B1 PYRIMIDINES AS INHIBITORS OF PHOSPHOINOSITIDE-3-KINASES (PI3K) WARNER LAMBERT CO (US) 2007-06-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227587-A1 Pyrimidines as inhibitors of phosphoinositide-3-kinases (PI3K) PIK3CA, PIK3CD, PIK3R5 ALDH1A1 2412/4885KDM4E 2264/4885MAPT 4425/4885
US-20150232474-A1 Bicyclic Substituted Pyrimidine Compounds DPYD, UMPS, TYMP ALDH1A1 912/4885KDM4E 3902/4885MAPT 2422/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.